About
Duel Composition Brain-Targeting Drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Team (3)
Enabling broad therapeutic discovery across brain indications
Brain-penetrant, target-specific drug engineered with a competing immunophilin binder
Montara Therapeutics
team_member
Management
Montara Therapeutics
team_member
Two-drug combination therapy to enable next-generation brain-targeting drugs
Montara Therapeutics
team_member
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...